S. Iacobelli

发表

The Cox shared frailty model with log-skew-normal frailties

A. Callegaro, S. Iacobelli, 2012 .

Analyzing differences between restricted mean survival time curves using pseudo-values

P. Andersen, S. Iacobelli, F. Ambrogi, 2020, BMC Medical Research Methodology.

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

M. Beksac, H. Goldschmidt, N. Kröger, 2013, Blood.

M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience

R. Foà, S. Iacobelli, F. Mandelli, 2008, Haematologica.

Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

M. Beksac, H. Goldschmidt, N. Kröger, 2015, Bone Marrow Transplantation.

Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation

S. Iacobelli, 2013, Bone Marrow Transplantation.

Survival probabilities with time‐dependent treatment indicator: quantities and non‐parametric estimators

S. Iacobelli, M. Valsecchi, P. Rebora, 2016, Statistics in medicine.

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion.

G. Mufti, N. Kröger, S. Iacobelli, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

John D Lambris, B. Nilsson, S. Iacobelli, 2020, Clinical Immunology.

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

B. Nilsson, S. Iacobelli, C. Garlanda, 2020, Clinical Immunology.

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.

A. Fischer, A. Ganser, S. Iacobelli, 2015, Blood.

Liposomal daunorubicin versus standard daunorubicin: long term follow‐up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

M. Baccarani, S. Iacobelli, M. Vignetti, 2008, British journal of haematology.

Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study.

S. Iacobelli, R. Brand, G. Gahrton, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.

S. Iacobelli, L. Biancone, E. Calabrese, 2012, Journal of Crohn's & colitis.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Paola Fazi, Marco Vignetti, Giuseppe Avvisati, 2013, The New England journal of medicine.

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant R

J. Bourhis, G. Mufti, N. Kröger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

A. Ganser, S. Iacobelli, M. Robin, 2021, Bone Marrow Transplantation.

Stem cell transplantation for chronic myeloid leukemia in children.

S. Iacobelli, R. Brand, G. Dini, 2003, Blood.

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia

B. Pégourié, S. Iacobelli, G. Gahrton, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?

S. Iacobelli, G. Gahrton, I. Yakoub-Agha, 2020, Journal of clinical medicine.

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

M. Kersten, S. Iacobelli, G. Gahrton, 2011 .

Primary plasma cell leukemia and autologous stem cell transplantation

S. Iacobelli, G. Gahrton, D. Niederwieser, 2010, Haematologica.

Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality.

S. Iacobelli, T. Pabst, P. Ljungman, 2020, The Journal of infection.

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

S. Iacobelli, T. Pabst, P. Ljungman, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

Riddhi A Modi, A. Krishnan, S. Iacobelli, 2020, Bone Marrow Transplantation.

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.

S. Iacobelli, G. Gahrton, C. Crawley, 2007, Blood.

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study.

N. Kröger, S. Iacobelli, I. Yakoub-Agha, 2021, Clinical lymphoma, myeloma & leukemia.

Efficacy and outcome of autologous transplantation in rare myelomas

H. Goldschmidt, G. Morgan, S. Iacobelli, 2009, Haematologica.

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

B. Nilsson, S. Iacobelli, J. Lambris, 2022, Science advances.

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

G. Mufti, S. Iacobelli, J. Sierra, 2006, Blood.

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

A. Ganser, J. Bourhis, S. Iacobelli, 2022, Bone Marrow Transplantation.

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

N. Kröger, S. Iacobelli, R. Brand, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.

W. Wiktor-Jedrzejczak, N. Kröger, S. Iacobelli, 2018, Biology of Blood and Marrow Transplantation.

Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

W. Wiktor-Jedrzejczak, N. Kröger, S. Iacobelli, 2017, Haematologica.

Design and Methods

S. Iacobelli, R. Brand, A. Nagler, 2022 .

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

A. Ganser, N. Kröger, S. Iacobelli, 2016 .

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

W. Wiktor-Jedrzejczak, N. Kröger, S. Iacobelli, 2019, Bone Marrow Transplantation.

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

H. Goldschmidt, N. Kröger, S. Iacobelli, 2006, Blood.

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)

S. Iacobelli, J. Snowden, J. Madrigal, 2019, Bone Marrow Transplantation.

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

G. Morgan, N. Kröger, S. Iacobelli, 2007, Haematologica.

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT

J. Johansson, N. Kröger, S. Iacobelli, 2020, British journal of haematology.

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.

H. Goldschmidt, H. Einsele, J. Johansson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

N. Kröger, S. Iacobelli, E. Tholouli, 2017, Haematologica.

Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT.

H. Goldschmidt, S. Iacobelli, G. Gahrton, 2009 .

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

N. Kröger, S. Iacobelli, A. Gratwohl, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

S. Iacobelli, J. Finke, P. Ljungman, 2010, Bone Marrow Transplantation.

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita

S. Iacobelli, J. Tolar, P. Veys, 2018, British journal of haematology.

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

N. Kröger, S. Iacobelli, A. Nagler, 2017, Haematologica.

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

S. Iacobelli, C. Craddock, P. Chevallier, 2016, Bone Marrow Transplantation.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

H. Einsele, S. Iacobelli, A. Tomaszewska, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

A. Ganser, G. Mufti, N. Kröger, 2021, British journal of haematology.

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.

G. Mufti, S. Iacobelli, N. Russell, 2022, The New England journal of medicine.

ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.

R. Foà, S. Iacobelli, S. Chiaretti, 2006, Blood.

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

N. Kröger, S. Iacobelli, G. Gahrton, 2013, Bone Marrow Transplantation.

Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma

N. Kröger, S. Iacobelli, G. Gahrton, 2015, Bone Marrow Transplantation.

Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.

H. Goldschmidt, S. Iacobelli, G. Gahrton, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT

N. Kröger, S. Iacobelli, C. Crawley, 2018, Haematologica.

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

S. Iacobelli, R. Brand, A. Gratwohl, 2002, Blood.

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

S. Montoto, N. Kröger, S. Iacobelli, 2019, Bone Marrow Transplantation.

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT

N. Kröger, S. Iacobelli, P. Chevallier, 2020, Bone Marrow Transplantation.

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants

N. Kröger, S. Iacobelli, A. Zander, 2005, Bone Marrow Transplantation.

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

N. Kröger, S. Iacobelli, M. Robin, 2021, Bone Marrow Transplantation.

Impact of T‐cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party

G. Mufti, S. Iacobelli, D. Blaise, 2018, American journal of hematology.

IMPACT OF T-CELL DEPLETION STRATEGIES ON OUTCOMES FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR IDIOPATHIC APLASTIC ANEMIA: A STUDY ON BEHALF OF THE EUROPEAN BLOOD AND MARROW TRANSPLANT (EBMT) SAA WORKING PARTY

Henrik, G. Mufti, S. Iacobelli, 2018 .

Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patients

S. Iacobelli, G. Ruvolo, C. Bassano, 2015, Heart and Vessels.

Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.

N. Kröger, S. Iacobelli, A. Zander, 2007, Anticancer research.

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

B. Pégourié, S. Iacobelli, G. Gahrton, 2010 .

Centre characteristics and procedure‐related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)

H. Putter, J. Delgado, N. Kröger, 2017, British journal of haematology.

Role of age and hematopoietic cell transplantation-specific comorbidity index in myelodysplastic patients undergoing an allotransplant. A retrospective study from the CMWP (Chronic Malignancies Working Party) of the EBMT.

R. Porcher, A. Ganser, N. Kröger, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

S. Iacobelli, G. Behre, D. Niederwieser, 2014, Leukemia & lymphoma.

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

N. Kröger, S. Iacobelli, A. Zander, 2005, British journal of haematology.

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

S. Iacobelli, D. Hasenclever, M. Mohty, 2022, Blood.

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

S. Montoto, S. Iacobelli, J. Sierra, 2022, Journal of clinical medicine.

Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

N. Kröger, S. Iacobelli, L. Kanz, 2020, Leukemia.

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT

N. Kröger, S. Iacobelli, M. Robin, 2014, Haematologica.